AbbVie Inc (NYSE:ABBV) on 06/23/2022 declared a dividend of $ 1.4100 per share payable on August 15, 2022 to shareholders of record as of July 15, 2022.
AbbVie Inc (NYSE:ABBV) has paid dividends since 2013, has a current dividend yield of 3.8221740723% and has increased its dividends for 8 successive years.
AbbVie Inc's market cap is $ 260,754,751,600 and has a PE ratio of 21.17. The stock price closed yesterday at $ 147.56 and has a 52 week low/high of $ 105.56 and $ 175.91.
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
For more information on AbbVie Inc click here.
AbbVie Inc current dividend information as per the date of this press release is: